| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | China | 3 | |
| #3 | India | 2 | |
| #4 | Canada | 1 | |
| #5 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Analysing materials | |
| #5 | Fermentation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Vermot-Desroches Claudine | 7 |
| #2 | Vermot-Desroches Claudine Brigitte Fernande | 4 |
| #3 | Vuillermoz Boris Sebastien | 4 |
| #4 | Bourdin Laurence Francoise Jeanne-Marie | 3 |
| #5 | Subiger Olivier Frederic | 3 |
| #6 | Subiger Olivier Frédéric | 2 |
| #7 | Mertani Hichem Claude | 1 |
| #8 | Vermot Desroches Claudine Brigitte Fernande | 1 |
| #9 | Albaret Marie Alexandra | 1 |
| #10 | Salles Gilles | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2016116635A1 | Anti-dr5 antibodies with enhanced apoptosis potency | |
| CN104619725A | Anti-DR5 family antibodies, bispecific or multivalent ANTI-DR5 family antibodies and methods of use thereof | |
| WO2012010602A1 | Method to improve glycosylation profile and to induce maximal cytotoxicity for antibody |